A Randomized, Open-label, Three-way Crossover Study to Evaluate the Relative Bioavailability of 200 Mg Cenobamate Administered Orally
Clinical trial NCT05572255 · COMPLETED
Trial details
- NCT number
- NCT05572255
- Sponsor
- SK Life Science, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-27
- Primary completion
- 2023-01-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.